0000899243-17-017408.txt : 20170628 0000899243-17-017408.hdr.sgml : 20170628 20170628171050 ACCESSION NUMBER: 0000899243-17-017408 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170621 FILED AS OF DATE: 20170628 DATE AS OF CHANGE: 20170628 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001325879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617- 531-2130 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAILEY MICHAEL P CENTRAL INDEX KEY: 0001255856 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34655 FILM NUMBER: 17936080 BUSINESS ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 6466385078 MAIL ADDRESS: STREET 1: IMCLONE SYSTEMS INCORPORATED STREET 2: 180 VARICK STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-21 0 0001325879 AVEO PHARMACEUTICALS INC AVEO 0001255856 BAILEY MICHAEL P C/O AVEO PHARMACEUTICALS, INC. ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 1 1 0 0 President & CEO Stock Option (right to buy) 0.60 2017-06-21 4 A 0 188666 0.00 A 2027-02-07 Common Stock 188666 188666 D On Febuary 8, 2017, the reporting person was granted an option to purchase 283,000 shares of common stock. Subject to the achievement of three performance milestones relating to the company's clinical trials and regulatory filings, one third of the option vests on February 8, 2018, and two thirds of the option vests on February 8, 2019. On June 21, 2017, the first two performance milestones were met. As a result, one third of the option will vest on February 8, 2018, and one third of the option will vest on February 8, 2019, in each case subject to the reporting person's continued service to the company. /s/ Michael P. Bailey 2017-06-28